The mitochondrial ADP/ATP carrier (SLC25 family): Pathological implications of its dysfunction

Molecular Aspects of Medicine

Volumn 34, Issue 2-3, 2013, Pages 485-493

  Clémençon, Benjamin ^a   Babot, Marion ^b   Trézéguet, Véronique ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b CNRS   (France)

^c CNRS   (France)

Author keywords

ADP ATP carrier; Cancer; Mitochondria; Model systems; Myopathies; Ophthalmoplegia

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BONGKREKIC ACID; CARBOXYATRACTYLOSIDE; MITOCHONDRIAL DNA;

APOPTOSIS; CANCER CELL; GENE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC REGULATION; GENOMICS; HETEROZYGOTE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; REVIEW; SLC25A31 GENE; SLC25A4 GENE; SLC25A5 GENE; SLC25A6 GENE; STRUCTURE ACTIVITY RELATION;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; ADENINE NUCLEOTIDE TRANSLOCATOR 2; ADENINE NUCLEOTIDE TRANSLOCATOR 3; AMINO ACID SEQUENCE; APOPTOSIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NEOPLASMS; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 84875131369     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2012.05.006     Document Type: Review

References (60)

1. S. Betina, G. Gavurnikova, P. Haviernik, L. Sabova, and J. Kolarov Expression of the AAC2 gene encoding the major mitochondrial ADP/ATP carrier in Saccharomyces cerevisiae is controlled at the transcriptional level by oxygen, heme and HAP2 factor Eur. J. Biochem. 229 1995 651 657
2. J.V. Brower, C.H. Lim, M. Jorgensen, S.P. Oh, and N. Terada Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells Reproduction 138 2009 463 470
3. N. Brustovetsky, and M. Klingenberg Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+ Biochemistry 35 1996 8483 8488
4. J.B. Chappell, and A.R. Crofts Calcium ion accumulation and volume changes of isolated liver mitochondria calcium ion-induced swelling. Biochem. J. 95 1965 378 386
5. X.J. Chen Introduction of an unregulated channel by mutations in adenine nucleotide translocase suggests an explanation for human ophthalmoplegia Hum. Mol. Genet. 11 2002 1835 1843
6. A. Chevrollier, D. Loiseau, B. Chabi, G. Renier, O. Douay, Y. Malthiery, and G. Stepien ANT2 isoform required for cancer cell glycolysis J. Bioenerg. Biomembr. 37 2005 307 316
7. A. Chevrollier, D. Loiseau, P. Reynier, and G. Stepien Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism Biochim. Biophys. Acta 1807 2010 562 567
8. B. Clémençon, M. Rey, V. Trézéguet, E. Forest, and L. Pelosi Yeast ADP/ATP carrier isoform 2: conformational dynamics and role of the RRRMMM signature sequence methionines J. Biol. Chem. 286 2011 36119 361131
9. E. Couplan, R.S. Aiyar, R. Kucharczyk, A. Kabala, N. Ezkurdia, J. Gagneur, R.P. St Onge, B. Salin, F. Soubigou, M. Le Cann, L.M. Steinmetz, J.P. di Rago, and M. Blondel A yeast-based assay identifies drugs active against human mitochondrial disorders Proc. Natl. Acad. Sci. U S A 108 2011 11989 11994
10. M. Crompton, A. Costi, and L. Hayat Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria Biochem. J. 245 1987 915 918
11. C. De Marcos Lousa, V. Trézéguet, A.C. Dianoux, G. Brandolin, and G.J.M. Lauquin The human mitochondrial ADP/ATP carriers: kinetic properties and biogenesis of wild-type and mutant proteins in yeast S. cerevisiae Biochemistry 41 2002 14412 14420
12. M. Deschauer, G. Hudson, T. Muller, R.W. Taylor, P.F. Chinnery, and S. Zierz A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia Neuromuscul. Disord. 15 2005 311 315
13. F. Di Lisa, and P. Bernardi Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole Cardiovasc. Res. 70 2006 191 199
14. V. Dolce, P. Scarcia, D. Iacopetta, and F. Palmieri A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution FEBS Lett. 579 2005 633 637
15. A. Dörner, S. Giessen, R. Gaub, H. Grosse Siestrup, P.L. Schwimmbeck, R. Hetzer, W. Poller, and H.P. Schultheiss An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy Eur. J. Heart Fail. 8 2006 81 89
16. R. Dörner, and H.P. Schultheiss The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy Herz 25 2000 176 180
17. T. Drgon, L. Sabova, N. Nelson, and J. Kolarov ADP/ATP translocator is essential only for anaerobic growth of yeast Saccharomyces cerevisiae FEBS Lett. 289 1991 159 162
18. J. Feng, E. Lucchinetti, G. Enkavi, Y. Wang, P. Gehrig, B. Roschitzki, M.C. Schaub, E. Tajkhorshid, K. Zaugg, and M. Zaugg Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria Am. J. Physiol. Cell. Physiol. 298 2010 740 748
19. F. Fontanesi, L. Palmieri, P. Scarcia, T. Lodi, C. Donnini, A. Limongelli, V. Tiranti, M. Zeviani, I. Ferrero, and A.M. Viola Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability Hum Mol. Genet. 13 2004 923 934
20. G. Forlani, E. Giarda, U. Ala, F. Di Cunto, M. Salani, R. Tupler, C. Kilstrup-Nielsen, and N. Landsberger The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis Hum. Mol. Genet. 19 2010 3114 3123
21. M.F. Giraud, and J. Velours The absence of the mitochondrial ATP synthase delta subunit promotes a slow growth phenotype of rho- yeast cells by a lack of assembly of the catalytic sector F1 Eur. J. Biochem. 245 1997 813 818
22. B.H. Graham, K.G. Waymire, B. Cottrell, I.A. Trounce, G.R. MacGregor, and D.C. Wallace A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator Nat. Genet. 16 1997 226 234
23. E.J. Griffiths, and A.P. Halestrap Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts J. Mol. Cell. Cardiol. 25 1993 1461 1469
24. V. Guillet, N. Gueguen, C. Verny, M. Ferre, C. Homedan, D. Loiseau, V. Procaccio, P. Amati-Bonneau, D. Bonneau, P. Reynier, and A. Chevrollier Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease Neurogenetics 11 2010 127 133
25. 2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase Biochem. J. 268 1990 153 160
26. T. Hamazaki, W.Y. Leung, B.D. Cain, D.A. Ostrov, P.E. Thorsness, and N. Terada Functional expression of human adenine nucleotide translocase 4 in Saccharomyces cerevisiae PLoS One 6 4 2011 e19250
27. A. Heddi, P. Lestienne, D.C. Wallace, and G. Stepien Steady state levels of mitochondrial and nuclear oxidative phosphorylation transcripts in Kearns-Sayre syndrome Biochim. Biophys. Acta 1226 1994 206 212
28. G. Hudson, P. Amati-Bonneau, E.L. Blakely, J.D. Stewart, L. He, A.M. Schaefer, P.G. Griffiths, K. Ahlqvist, A. Suomalainen, and P. Reynier Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: A novel disorder of mtDNA maintenance Brain 131 2008 329 337
29. D.R. Hunter, and R.A. Haworth The Ca2+-induced membrane transition in mitochondria. I The protective mechanisms. Arch. Biochem. Biophys. 195 1979 453 459
30. D.R. Hunter, R.A. Haworth, and J.H. Southard Relationship between configuration, function, and permeability in calcium-treated mitochondria J. Biol. Chem. 251 1976 5069 5077
31. E.Z. Jordens, L. Palmieri, M. Huizing, L.P. van den Heuvel, R.C. Sengers, A. Dörner, W. Ruitenbeek, F.J. Trijbels, J. Valsson, G. Sigfusson, F. Palmieri, and J.A. Smeitink Adenine nucleotide translocator 1 deficiency associated with Sengers syndrome Ann. Neurol. 52 2002 95 99
32. M. Juhaszova, S. Wang, D. Zorov, H.B. Nuss, M. Gleichmann, M.P. Mattson, and S. Solloti The identity and regulation of the mitochondrial permeability transition pore. Where the known meets the unknown Ann. N. Y. Acad. Sci. 1123 2008 197 212
33. J. Kaukonen, J.K. Juselius, V. Tiranti, A. Kyttala, M. Zeviani, G.P. Comi, S. Keranen, L. Peltonen, and A. Suomalainen Role of adenine nucleotide translocator 1 in mtDNA maintenance Science 289 2000 782 785
34. L.A. Kelley, and M.J. Sternberg Protein structure prediction on the web: a case study using the Phyre server Nat. protoc. 4 2009 363 371
35. Y.H. Kim, G. Haidl, M. Schaefer, U. Egner, A. Mandal, and J.C. Herr Compartmentalization of a unique ADP/ATP carrier protein SFEC (Sperm Flagellar Energy Carrier, AAC4) with glycolytic enzymes in the fibrous sheath of the human sperm flagellar principal piece Dev. Biol. 302 2007 463 476
36. M. Klingenberg The ADP and ATP transport in mitochondria and its carrier Biochim. Biophys. Acta 1778 2008 1978 2021
37. J.E. Kokoszka, K.G. Waymire, S.E. Levy, J.E. Sligh, J. Cai, D.P. Jones, G.R. MacGregor, and D.C. Wallace The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore Nature 427 2004 461 465
38. M.A. Larkin, G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. Valentin, I.M. Wallace, A. Wilm, R. Lopez, J.D. Thompson, T.J. Gibson, and D.G. Higgins Clustal W and Clustal X version 2.0 Bioinformatics 23 2007 2947 2948
39. M. Le Bras, A. Borgne-Sanchez, Z. Touat, O.S. El Dein, A. Deniaud, E. Maillier, G. Lecellier, D. Rebouillat, C. Lemaire, G. Kroemer, E. Jacotot, and C. Brenner Chemosensitization by knockdown of adenine nucleotide translocase-2 Cancer Res. 66 2006 9143 9152
40. K. Le Quoc, and D. Le Quoc Involvement of the ADP/ATP carrier in calcium-induced perturbations of the mitochondrial inner membrane permeability: importance of the orientation of the nucleotide binding site Arch. Biochem. Biophys. 265 1988 249 257
41. J.A. Mayr, F.A. Zimmermann, R. Horvath, H.C. Schneider, B. Schoser, E. Holinski-Feder, B. Czermin, P. Freisinger, and W. Sperl Deficiency of the mitochondrial phosphate carrier presenting as myopathy and cardiomyopathy in a family with three affected children Neuromuscul. Disord. 21 2011 803 808
42. R. Moreno-Sanchez, S. Rodriguez-Enriquez, A. Marin-Hernandez, and E. Saavedra Energy metabolism in tumor cells FEBS J. 274 2007 1393 1418
43. S.M. Nadtochiy, Q. Zhu, W. Urciuoli, R. Rafikov, S.M. Black, and P.S. Brookes Nitroalkenes confer acute cardioprotection via adenine nucleotide translocase 1 J. Biol. Chem. 287 2012 3573 3580
44. W. Nazareth, N. Yafei, and M. Crompton Inhibition of anoxia-inducedinjury in heart myocytes by cyclosporin A J. Mol. Cell. Cardiol. 23 1991 1351 1354
45. H. Nury, C. Dahout-Gonzalez, V. Trézéguet, G.J.-M. Lauquin, G. Brandolin, and E. Pebay-Peyroula Relations between structure and function of the mitochondrial ADP/ATP carrier Annu. Rev. Biochem. 75 2006 713 741
46. L. Palmieri, S. Alberio, I. Pisano, T. Lodi, M. Meznaric-Petrusa, J. Zidar, A. Santoro, P. Scarcia, F. Fontanesi, E. Lamantea, I. Ferrero, and M. Zeviani Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy Hum. Mol. Genet. 14 2005 3079 3088
47. E. Pebay-Peyroula, C. Dahout-Gonzalez, R. Kahn, V. Trézé guet, G.J.-M. Lauquin, and G. Brandolin Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside Nature 426 2003 39 44
48. E.E. Ramsay, P.J. Hogg, and P.J. Dilda Mitochondrial metabolism inhibitors for cancer therapy Pharm. Res. 28 2011 2731 2744
49. M.G. Rosca, I.A. Okere, N. Sharma, W.C. Stanley, F.A. Recchia, and C.L. Hoppel Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure J. Mol. Cell. Cardiol. 46 2009 927 935
50. M. Santamaria, C. Lanave, and C. Saccone The evolution of the adenine nucleotide translocase family Gene 333 2004 51 59
51. R. Slim, J. Levilliers, H.J. Ludecke, U. Claussen, V.C. Nguyen, N.M. Gough, B. Horsthemke, and C. Petit A human pseudoautosomal gene encodes the ANT3 ADP/ATP translocase and escapes X-inactivation Genomics 16 1993 26 33
52. G. Stepien, A. Torroni, A.B. Chung, J.A. Hodge, and D.C. Wallace Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation J. Biol. Chem. 267 1992 14592 14597
53. M. Stubbs, and J.R. Griffiths The altered metabolism of tumors: HIF-1 and its role in the Warburg effect Adv. Enzyme Regul. 50 2010 44 55
54. The 1000 Genomes Project Consortium, 2010. A map of human genome variation from population-scale sequencing. Nature (London) 467, 1061-1073.
55. J. Traba, J. Satrustegui, and A. del Arco Adenine nucleotide transporters in organelles: novel genes and functions Cell. Mol. Life Sci. 68 2011 1183 1206
56. V. Trézéguet, L. Pelosi, G.J.-M. Lauquin, and G. Brandolin The mitochondrial ADP/ATP carrier: functional and structural studies in the route of elucidating pathophysiological aspects J. Bioenerg. Biomembr. 40 2008 435 443
57. H. Tyynismaa, E. Ylikallio, M. Patel, M.J. Molnar, R.G. Haller, and A. Suomalainen A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions Am. J. Hum. Genet. 85 2009 290 295
58. C. Wang, and R.J. Youle The role of mitochondria in apoptosis Annu. Rev. Genet. 43 2009 95 118
59. K. Woodfield, A. Rück, D. Brdiczka, and A.P. Halestrap Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition Biochem. J. 336 1998 287 290
60. H. Yin, J.S. Stahl, F.H. Andrade, C.A. McMullen, S. Webb-Wood, N.J. Newman, V. Biousse, D.C. Wallace, and M.T. Pardue Eliminating the Ant1 isoform produces a mouse with CPEO pathology but normal ocular motility Invest. Ophthalmol. Vis. Sci. 46 2005 4555 4562